GlassScriptPhysician profile
Robert David Graham
NPI 1831504885
$62,398.86
in general payments reported to CMS, 2019-2025
25 companies · $860 in 2025
The $860 reported for 2025 was more than what a typical Surgery of The Hand (Surgery) provider received nationally (typical 2025 total: $285).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $14K · 2020: $546 · 2021: $6,264 · 2022: $1,577 · 2023: $451 · 2024: $39K · 2025: $860.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $35K · Food and Beverage: $2,643 · Travel and Lodging: $2,540.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $34,855.13 |
| Food and Beverage | $2,642.89 |
| Travel and Lodging | $2,539.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $37,608.38 | 2019-2025 | Aequalis Perform, Latitude Ev, Pangea |
| Arthrex, INC. | $13,817.35 | 2019-2024 | |
| Team 1, LLC | $6,884.14 | 2021-2025 | |
| Medical Device Business Services, INC. | $1,861.75 | 2019-2020 | |
| Acumed LLC | $617.51 | 2022-2024 | Acumed, Osteomed |
| Axogen | $412.41 | 2019-2025 | Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Ha+ Nerve Protector |
| Smith+Nephew, INC. | $291.61 | 2020-2024 | Bone Anchors With Arthroscopic Delivery System, Bioinductive Implant With Arthroscopic Delivery System - Medium |
| Ebi, LLC | $192.17 | 2025 | Biomet Spinalpak Non-Invasive Spine Fusion Stimulator System |
| Endo Pharmaceuticals INC. | $127.72 | 2019-2021 | |
| Medartis INC. | $93.33 | 2020 | |
| Zimmer Biomet Holdings, INC. | $59.32 | 2025 | Persona, Gel-One Cross-Linked Hyaluronate, Mymobility Platform |
| Highridge Medical LLC | $58.47 | 2025 | Biomet Spinalpak Non-Invasive Spine Fusion Stimulator System |
| Depuy Synthes Sales INC. | $58.27 | 2023-2024 | Monovisc, Orthovisc |
| Biotissue Holdings INC. | $56.45 | 2022-2024 | |
| Vertex Pharmaceuticals Incorporated | $53.42 | 2025 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Access Pro Medical, LLC | $31.84 | 2023 | Matriderm |
| Ermi LLC | $31.29 | 2021 | |
| Dynasplint Systems INC. | $26.92 | 2023-2025 | Dynasplint |
| Bioventus LLC | $24.27 | 2025 | Durolane |
| Endo USA, INC. | $18.89 | 2024 | Xiaflex |
| Zimvie INC. | $17.88 | 2023 | |
| Mimedx Group, INC. | $14.33 | 2025 | |
| Checkpoint Surgical, INC | $13.94 | 2021 | |
| Innovation Technologies INC | $13.63 | 2025 | Irrisept |
| Orthofix Medical, INC. | $13.57 | 2025 | Physio-Stim |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Graham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.